180 related articles for article (PubMed ID: 37511044)
21. Multiplexed Gene Editing and Protein Overexpression Using a
Cody WB; Scholthof HB; Mirkov TE
Plant Physiol; 2017 Sep; 175(1):23-35. PubMed ID: 28663331
[TBL] [Abstract][Full Text] [Related]
22. CRISPR-Cas9 mediated targeted disruption of FAD2-2 microsomal omega-6 desaturase in soybean (Glycine max.L).
Al Amin N; Ahmad N; Wu N; Pu X; Ma T; Du Y; Bo X; Wang N; Sharif R; Wang P
BMC Biotechnol; 2019 Jan; 19(1):9. PubMed ID: 30691438
[TBL] [Abstract][Full Text] [Related]
23. Speed genome editing by transient CRISPR/Cas9 targeting and large DNA fragment deletion.
Luo J; Lu L; Gu Y; Huang R; Gui L; Li S; Qi X; Zheng W; Chao T; Zheng Q; Liang Y; Zhang L
J Biotechnol; 2018 Sep; 281():11-20. PubMed ID: 29886029
[TBL] [Abstract][Full Text] [Related]
24. Gene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission.
Peng C; Yan Y; Kim VJ; Engle SE; Berry JN; McIntosh JM; Neve RL; Drenan RM
Eur J Neurosci; 2019 Aug; 50(3):2224-2238. PubMed ID: 29779223
[TBL] [Abstract][Full Text] [Related]
25. Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth.
Nakazawa T; Natsume A; Nishimura F; Morimoto T; Matsuda R; Nakamura M; Yamada S; Nakagawa I; Motoyama Y; Park YS; Tsujimura T; Wakabayashi T; Nakase H
Cells; 2020 Apr; 9(4):. PubMed ID: 32316275
[TBL] [Abstract][Full Text] [Related]
26. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
[TBL] [Abstract][Full Text] [Related]
27. A stable DNA-free screening system for CRISPR/RNPs-mediated gene editing in hot and sweet cultivars of Capsicum annuum.
Kim H; Choi J; Won KH
BMC Plant Biol; 2020 Oct; 20(1):449. PubMed ID: 33004008
[TBL] [Abstract][Full Text] [Related]
28. Application of CRISPR in Filamentous Fungi and Macrofungi: From Component Function to Development Potentiality.
Shen JY; Zhao Q; He QL
ACS Synth Biol; 2023 Jul; 12(7):1908-1923. PubMed ID: 37404005
[TBL] [Abstract][Full Text] [Related]
29. CRISPR-Cas9 recognition of enzymatically synthesized base-modified nucleic acids.
Yang H; Eremeeva E; Abramov M; Jacquemyn M; Groaz E; Daelemans D; Herdewijn P
Nucleic Acids Res; 2023 Feb; 51(4):1501-1511. PubMed ID: 36611237
[TBL] [Abstract][Full Text] [Related]
30. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
31. In Vivo Genome Editing in Type I and II Methanotrophs Using a CRISPR/Cas9 System.
Rumah BL; Claxton Stevens BH; Yeboah JE; Stead CE; Harding EL; Minton NP; Zhang Y
ACS Synth Biol; 2023 Feb; 12(2):544-554. PubMed ID: 36688528
[TBL] [Abstract][Full Text] [Related]
32. A piggyBac-based toolkit for inducible genome editing in mammalian cells.
Schertzer MD; Thulson E; Braceros KCA; Lee DM; Hinkle ER; Murphy RM; Kim SO; Vitucci ECM; Calabrese JM
RNA; 2019 Aug; 25(8):1047-1058. PubMed ID: 31101683
[TBL] [Abstract][Full Text] [Related]
33. CES1-Triggered Liver-Specific Cargo Release of CRISPR/Cas9 Elements by Cationic Triadic Copolymeric Nanoparticles Targeting Gene Editing of PCSK9 for Hyperlipidemia Amelioration.
Zhao Y; Li Y; Wang F; Gan X; Zheng T; Chen M; Wei L; Chen J; Yu C
Adv Sci (Weinh); 2023 Jul; 10(19):e2300502. PubMed ID: 37083231
[TBL] [Abstract][Full Text] [Related]
34. Progress of delivery methods for CRISPR-Cas9.
Yang W; Yan J; Zhuang P; Ding T; Chen Y; Zhang Y; Zhang H; Cui W
Expert Opin Drug Deliv; 2022 Aug; 19(8):913-926. PubMed ID: 35818792
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.
Ozyerli-Goknar E; Kala EY; Aksu AC; Bulut I; Cingöz A; Nizamuddin S; Biniossek M; Seker-Polat F; Morova T; Aztekin C; Kung SHY; Syed H; Tuncbag N; Gönen M; Philpott M; Cribbs AP; Acilan C; Lack NA; Onder TT; Timmers HTM; Bagci-Onder T
Cell Commun Signal; 2023 Nov; 21(1):328. PubMed ID: 37974198
[TBL] [Abstract][Full Text] [Related]
36. Improving a Quantitative Trait in Rice by Multigene Editing with CRISPR-Cas9.
Yimam YT; Zhou J; Akher SA; Zheng X; Qi Y; Zhang Y
Methods Mol Biol; 2021; 2238():205-219. PubMed ID: 33471333
[TBL] [Abstract][Full Text] [Related]
37. Generation of Cashmere Goats Carrying an
Hao F; Yan W; Li X; Wang H; Wang Y; Hu X; Liu X; Liang H; Liu D
Int J Biol Sci; 2018; 14(4):427-436. PubMed ID: 29725264
[TBL] [Abstract][Full Text] [Related]
38. Frequency of off-targeting in genome edited pigs produced via direct injection of the CRISPR/Cas9 system into developing embryos.
Carey K; Ryu J; Uh K; Lengi AJ; Clark-Deener S; Corl BA; Lee K
BMC Biotechnol; 2019 May; 19(1):25. PubMed ID: 31060546
[TBL] [Abstract][Full Text] [Related]
39. [Construction of macrophage RAW 264.7 cells with
Zhou L; Ye Y; Yuan H; Wu C; Wu S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):116-122. PubMed ID: 33509763
[TBL] [Abstract][Full Text] [Related]
40. Enhanced Genome Editing Tools For Multi-Gene Deletion Knock-Out Approaches Using Paired CRISPR sgRNAs in CHO Cells.
Schmieder V; Bydlinski N; Strasser R; Baumann M; Kildegaard HF; Jadhav V; Borth N
Biotechnol J; 2018 Mar; 13(3):e1700211. PubMed ID: 28976642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
